La Jolla Pharmaceutical Company. (LJPC) Reports Q2 Loss of $0.63/Share
Tweet
Share
E-mailGet Alerts LJPC Hot Sheet
Price: $6.22 --0%
Financial Fact:
Loss from operations: -15.62M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Financial Fact:
Loss from operations: -15.62M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
La Jolla Pharmaceutical Company. (NASDAQ: LJPC) reported Q2 EPS of ($0.63), versus ($6.77) reported last year.
For earnings history and earnings-related data on La Jolla Pharmaceutical Company. (LJPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TechnipFMC (FTI) Tops Q1 EPS by 6c, provides guidance
- S&P Global (SPGI) Tops Q1 EPS by 36c; offers guidance
- Expro Group Holdings N.V. (XPRO) Reports In-Line Q1 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
